For patients with cardiovascular or kidney disease, SGLT2 inhibitors or GLP-1 receptor agonists (oral or injectable) may be considered as part of first-line therapy for their cardiorenal benefits
1 To help patients understand dosing with KESIMPTA, share the instructions below: Initial dosing of 20 mg by SC injection at weeks 0, 1, and 2, followed by subsequent dosing of 20 mg by SC injection once monthly starting at week 4
Agencies like Swissmedic have raised red flags regarding ingredient inconsistencies and formulation quality
PE-22-28, as a newer and less widely produced compound, may carry premium pricing
This dual-action pathway activates efficient fat metabolism, optimizing your body's ability to burn calories as clean fuel while remaining gentle enough for daily, long-term use
Ther-Biotic Complete provides a broad-spectrum approach to gut health